A, D. R., L, M., MP, D., EC, T., A, D. S., & I, C. (2024). Advancements in Inflammatory Bowel Disease Management: From Traditional Treatments to Monoclonal Antibodies and Future Drug Delivery Systems. Pharmaceutics, 16(9), . https://doi.org/10.3390/pharmaceutics16091185
Chicago Style (17th ed.) CitationA, Di Rienzo, Marinelli L, Dimmito MP, Toto EC, Di Stefano A, and Cacciatore I. "Advancements in Inflammatory Bowel Disease Management: From Traditional Treatments to Monoclonal Antibodies and Future Drug Delivery Systems." Pharmaceutics 16, no. 9 (2024). https://doi.org/10.3390/pharmaceutics16091185.
MLA (9th ed.) CitationA, Di Rienzo, et al. "Advancements in Inflammatory Bowel Disease Management: From Traditional Treatments to Monoclonal Antibodies and Future Drug Delivery Systems." Pharmaceutics, vol. 16, no. 9, 2024, https://doi.org/10.3390/pharmaceutics16091185.